News About: Pharm. Industry
ED medication Zydena launched in Turkey
Dong-A Pharmaceutical Co. announced Monday that its erectile dysfunction (ED) drug Zydena (udenafil) has been marketed in Turkey, following Russia.
Under the terms of the agreement, Abdi Ibrahim Pharmaceuticals may...
Restructuring lurks in pharmaceutical sector
Korea’s pharmaceutical sector is poised to head for a fresh round of restructuring, with many drug makers pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook d...
Drug companies squeezed by government
A chief executive of one of the leading drug companies in Korea expressed concern about the country’s pharmaceutical industry.
“We will have to make all-out to increase this year’s sales by at least 30 percent to m...
Hanmi’s IMD pidogul approved in Italy
Hanmi Pharmaceutical announced Monday that the firm received an approvable letter for Pidogul (clopidogrel napadisilate monohydrate) tablets, one of its incrementally modified drugs (IMDs), from Italian health authori...
Foreign drugmakers spur OTC sales
Multinational drug manufacturers, including Wyeth and Novartis, are focusing on boosting the sales of their flagship OTC (over-the-counter) drugs by offering a variety of incentives.
Facing the massive drug price c...
Civic group calls for scrapping of market based incentive system
The Citizens' Coalition for Economic Justice (CCEJ) said Wednesday that the current drug pricing system, designed to offer hospitals and pharmacies an incentive to purchase drugs from pharmaceutical companies as cheap...
Two drugmakers to be made public by FTC
Korea’s antitrust regulator announced Wednesday that Myungmoon Pharmaceutical Co. was found to have provided 3.6 billion won to doctors and hospitals in return for prescribing, purchasing or recommending their product...
Ilyang’s new leukemia drug approved in Korea
Local drugmaker Ilyang Pharmaceutical said Thursday that the Korea Food and Drug Administration has approved its highly-anticipated leukemia medicine, the 18th-domestically-made medication.
The drug will be indicat...
Radotinib to take on Gleevec, Sprycel
Radotinib is Korea’s 18th homegrown leukemia drug and the world’s fifth and was approved by the Korea Food and Drug Administration on January 4.
Market watchers say the new drug is likely to bring a huge change to ...
Can Rhu Duk-hee retake the helm of KPMA?
Keen attention has been paid to the re-appointment of Rhu Duk-hee, incumbent chairman of the Korea Pharmaceutical Manufacturers Association and chairman of Kyungdong Pharmaceutical Co.
According to industry observe...
